| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01876251 2013-000659-41 Details | 2019-03-15 Interventional | 1 | 30 | Docetaxel Nirogacestat Breast Neoplasm… Breast Cancer M… | The study was terminated on June 24th, 2015 due to change in strategy of PF-03084014
development. There were no safety/efficacy concerns behind the decision. - | |||
| NCT01760252 Details | 2019-03-15 Interventional | 2 | 17 | Capecitabine Irinotecan Oxaliplatin Adenocarcinoma Metastatic Panc… | - - | |||
| NCT01370694 2011-000386-13 Details | 2019-03-15 Interventional | 1 | 7 | Cyclophosphamid… Prednisolone Vincristine Lymphoma Lymphoma, Folli… Follicular Lymp… | The study was terminated for business reasons. The study was terminated for business reasons. Not all planned analyses were performed | |||
| NCT03028909 Details | 2019-03-14 Interventional | 2 | 0 | MEDI8852 Oseltamivir Influenza, Huma… Sprains and Str… Influenza - Typ… | Study is withdrawn due to company decision. - | |||
| NCT01283386 Details | 2019-03-14 Interventional | 4 | 26 | Chlorambucil Cyclophosphamid… Fludarabine Rituximab Leukemia Leukemia, Lymph… Leukemia, Lymph… Lymphocytic Leu… | - - | |||
| NCT00561067 Details | 2019-03-14 Interventional | 3 | 10 | Epoetin Alfa Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Spinal Cord Inj… Spinal Cord Inj… | Italian Medicines Agency decision - | |||
| NCT03805672 Details | 2019-03-13 Interventional | 4 | 4 | Enoxaparin Enoxaparin sodi… Thrombosis Venous Thrombos… Blood Clots Deep Vein Throm… | Terminated due to low enrollment because of decrease in DVT rates. - | |||
| NCT02630472 Details | 2019-03-13 Interventional | 1/2 | 10 | Quinine Rhinitis Sinusitis | Institutional decision - | |||
| NCT02407223 2015-000289-67 Details | 2019-03-13 Interventional | 3 | 356 | Ustekinumab Axial Spondyloa… Non-Radiographi… Spondylarthriti… Spondylitis Spondylitis, An… Nonradiographic… | This study was stopped because ustekinumab did not achieve key endpoints in a related study.
The safety profile was consistent with past ustekinumab studies. The study was discontinued before it was fully enrolled, therefore, the interpretation of the efficacy data is limited. | |||
| NCT00662077 Details | 2019-03-13 Interventional | 4 | 0 | Ibandronic Acid Osteoporosis HIV Infections | Financial difficulties - | |||
| NCT03809897 Details | 2019-03-12 Interventional | 4 | 0 | Nicotine Varenicline Mental Disorder… Problem Behavio… Psychiatric Dis… Tobacco Use Ces… | Budget not sufficient to cover the study scope proposed and recruitment rates expected to be no
sufficient. - | |||
| NCT03369782 Details | 2019-03-12 Interventional | 4 | 0 | Rocuronium Pain, Postopera… Postoperative P… Surgery | refocusing of research priorities - | |||
| NCT02948101 Details | 2019-03-12 Interventional | 2 | 0 | Antibodies Antibodies, Mon… Cyclophosphamid… Carcinoma Recurrence Recurrent Fallo… Recurrent Ovari… Recurrent Prima… | PI's request - | |||
| NCT02525302 Details | 2019-03-12 Interventional | 2 | 10 | Halofuginone Muscular Dystro… Muscular Dystro… Duchenne Muscul… | Dosing stopped - | |||
| NCT01191034 Details | 2019-03-12 Interventional | 1/2 | 2 | Imiquimod Melanoma Metastatic Mela… | Completion after 2 patients then stop due to end of validity of vaccine peptide - | |||
| NCT03468829 2017-003356-23 Details | 2019-03-11 Interventional | 2 | 0 | Gontivimab Communicable Di… Infections Respiratory Tra… Respiratory Syn… | ALX-0171 development program was stopped - | |||
| NCT03705858 Details | 2019-03-08 Interventional | 1 | 0 | Lintuzumab Leukemia Leukemia, Myelo… Leukemia, Myelo… Acute Myeloid L… | Due to difficulty in finalizing the contract - | |||
| NCT03196921 Details | 2019-03-08 Interventional | 1/2 | 0 | Amphotericin B Liposomal ampho… Communicable Di… Infections Cryptococcal In… | Protocol redundancy - | |||
| NCT03187691 Details | 2019-03-08 Interventional | 2 | 0 | Amphotericin B Liposomal ampho… Leukemia Leukemia, Lymph… Precursor Cell … Acute Lymphobla… Acute Myeloid L… | Protocol redundancy - | |||
| NCT03167957 Details | 2019-03-08 Interventional | 2 | 0 | Amphotericin B Liposomal ampho… Candidiasis Candidiasis, Vu… Communicable Di… Infections Mycoses Vulvovaginitis Vulvovaginal Ca… Yeast Infection Yeast Infection… | No longer target indication - |